Targanta Therapeutics
1997
FOUNDED
M&A
STATUS
21-30
EMPLOYEES
M&A
LATEST DEAL TYPE
$42M
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of innovative antibiotics to treat serious infections in the hospital and other institutional settings. The company develops antibiotics for the treatment of serious gram-positive bacterial infections, including complicated skin and skin structure infections.
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 222 Third Street
- Suite 2300
- Cambridge, MA 02142
- United States
+1 (514) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Targanta Therapeutics’s full profile, request a free trial.
Targanta Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 26-Feb-2009 | $42M | 00000 | 0000 | Completed | Clinical Trials - Phase 3 |
| 6. IPO | 10-Oct-2007 | 000.00 | 00000 | 00000 | Completed | Clinical Trials - Phase 3 |
| 5. Later Stage VC (Series C3) | 12-Feb-2007 | 000.00 | 00000 | 00000 | Completed | Generating Revenue |
| 4. Later Stage VC (Series C2) | 06-Jan-2005 | 0000 | 0000 | 000.00 | Completed | Generating Revenue |
| 3. Later Stage VC (Series C1) | 12-Mar-2002 | 000.00 | 0000 | 000.00 | Completed | Generating Revenue |
| 2. Early Stage VC (Series B) | 01-Dec-1999 | $28.7M | $30.3M | 000.00 | Completed | Product Development |
| 1. Seed Round | 01-Dec-1997 | $1.58M | $1.58M | 00.000 | Completed | Startup |
Targanta Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series C3 | 0,000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
| Series C2 | 0,000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
| Series C1 | 0,000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
| Series B | 245,000 | $0.000100 | 8% | $199.5 | $199.5 | 1x | $199.5 | 1.35% |
| Series A | 20,000 | $0.000100 | $101.12 | $101.12 | 1x | $101.12 | 0.15% |
Targanta Therapeutics Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Brookside Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Fonds de solidarité FTQ | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| GrowthWorks | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| InterMune | Corporation | 000 0000 | 000000 0 | |||
| Le Centre CDP Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
Targanta Therapeutics Executive Team (7)
3 Former Executives
You’re viewing 4 of 7 executives. Get the full list »